4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-103540
President and CEO acquired 718,262 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KIDRON NADAV President and CEO | 2026-09-24 | Grant or award | +349,497 | 3,771,740 | D | ||
| KIDRON NADAV President and CEO | 2026-09-24 | Grant or award | +368,765 | 4,140,505 | D | ||
| Derivatives | |||||||
| KIDRON NADAV President and CEO | 2026-09-24 | Returned to the company · Stock option (right to buy) | −196,500 | 0 | D | ||
| KIDRON NADAV President and CEO | 2026-09-24 | Returned to the company · Stock option (right to buy) | −190,000 | 0 | D | ||
| KIDRON NADAV President and CEO | 2026-09-24 | Returned to the company · Stock option (right to buy) | −49,000 | 0 | D | ||
| KIDRON NADAV President and CEO | 2026-09-24 | Returned to the company · Stock option (right to buy) | −97,000 | 0 | D | ||
| KIDRON NADAV President and CEO | 2026-09-24 | Returned to the company · Stock option (right to buy) | −150,000 | 0 | D | ||
| KIDRON NADAV President and CEO | 2026-09-24 | Returned to the company · Stock option (right to buy) | −107,000 | 0 | D | ||
Loading xslF345X06/ownership.xml…